Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Evaluating cardiovascular risk assessment for asymptomatic people.

Scott IA.

BMJ. 2009 Jan 5;338:a2844. doi: 10.1136/bmj.a2844. Review. No abstract available.

PMID:
19124547
2.

Integration of the clinical laboratory in cardiovascular medicine.

McCullough PA.

Rev Cardiovasc Med. 2010;11 Suppl 2:S1-2. Review. No abstract available.

PMID:
20700097
3.

Screening for asymptomatic cardiovascular disease in Arab patients with diabetes.

Elsharawy MA, Al-Elq AH, Alkhadra AH, Moghazy KM, Elsaid AS.

Int Angiol. 2011 Feb;30(1):52-7.

PMID:
21248673
4.

Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality.

De Bacquer D, De Backer G.

Int J Cardiol. 2010 Sep 3;143(3):385-90. doi: 10.1016/j.ijcard.2009.03.101.

PMID:
19386372
5.

Novel cardiac markers.

Alder R.

Adv Nurse Pract. 2009 Jun;17(6):24-7; quiz 28. No abstract available.

PMID:
20000180
6.

The ageing athlete: screening prior to vigorous exertion in asymptomatic adults without known cardiovascular disease.

Freeman J, Froelicher V, Ashley E.

Br J Sports Med. 2009 Sep;43(9):696-701. doi: 10.1136/bjsm.2008.054783. Review.

PMID:
19734505
7.

Noninvasive assessment of cardiovascular risk: from Framingham to the future.

Vogel RA, Benitez RM.

Rev Cardiovasc Med. 2000 Summer;1(1):34-42. Review.

PMID:
12457150
8.

A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.

Petersson U, Ostgren CJ, Brudin L, Nilsson PM.

Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):536-40. doi: 10.1097/HJR.0b013e32832b1833.

PMID:
19357517
9.

Diagnostic testing of cardiac function.

Shapiro TA, Coady PM.

Occup Med. 1997 Jul-Sep;12(3):513-23. Review.

PMID:
9298497
10.

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.

Fortmann SP, Ford E, Criqui MH, Folsom AR, Harris TB, Hong Y, Pearson TA, Siscovick D, Vinicor F, Wilson PF; CDC.; AHA..

Circulation. 2004 Dec 21;110(25):e554-9.

11.

[Cardiovascular monitoring of patients with systemic lupus erythematosus].

Schotte H, Becker H, Domschke W, Gaubitz M.

Z Rheumatol. 2005 Nov;64(8):564-75. German.

PMID:
16328762
12.
13.
14.
15.

Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronóstico de la Angina (PEPA).

López de Sá E, López-Sendón J, Anguera I, Bethencourt A, Bosch X; Proyecto de Estudio del Pronostico de la Angina (PEPA) Investigators..

Medicine (Baltimore). 2002 Nov;81(6):434-42.

16.

High sensitivity C-reactive protein: can it predict cardiovascular risk in postmenopausal women?

Drown DJ.

Prog Cardiovasc Nurs. 2000 Fall;15(4):152-3. No abstract available.

PMID:
11098530
17.

Non-invasive assessment of the risk of coronary heart disease.

Richie RC.

J Insur Med. 2002;34(1):31-42. Review.

PMID:
15303592
18.

Evaluating risk for cardiovascular diseases--vain or value? How do different cardiovascular risk scores act in real life.

Ketola E, Laatikainen T, Vartiainen E.

Eur J Public Health. 2010 Feb;20(1):107-12. doi: 10.1093/eurpub/ckp070.

19.

Screening for safe sports participation: do for yourself what you tell your patients.

Heidbuchel H.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S14-6. doi: 10.1097/01.hjr.0000359229.35152.d4. No abstract available.

PMID:
19675429
20.

[Clinical significance of high-sensitivity C-reactive protein].

Ueno H.

Nihon Rinsho. 2006 Aug;64 Suppl 6:137-41. Review. Japanese. No abstract available.

PMID:
16983765
Items per page

Supplemental Content

Support Center